DAVA Will Distribute IMPAX's Generic OxyContin

Drug Industry Daily
KEYWORDS Deals
A A

IMPAX Laboratories has signed a supply and distribution deal under which DAVA Pharmaceuticals will market IMPAX's oxycodone HCl extended-release tablets in the U.S. and Puerto Rico.

To View This Article:

Login

Subscribe To Drug Industry Daily